LifeGuide

Awareness Is Key What You Need to Know About the Side Effect Profiles of New HCV Antiretrovirals by Larry Buhl By all accounts, adding the new direct-acting...

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...

When it comes to diarrhea, oral rehydration is a neglected but effective therapy by Mariel Selbovitz, MPH [WELLNESS WATCH} Diarrhea is one of the most annoying and...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

Entry inhibitors usher in a new phase of hep C research by Larry Buhl Future therapy for hepatitis C infection may include a variety of drugs...

HIVHealthReform.org offers chances to learn about & advocate for new policies by Chael Needle The Patient Protection and Affordable Care Act, created by the Obama administration,...

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

LifeGuide Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested...

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...